case 4: treating egfr nsclc after osimertinib
Published 5 years ago • 2.9K plays • Length 6:55Download video MP4
Download video MP3
Similar videos
-
5:24
case 4: egfr mutation analysis post-osimertinib
-
6:41
case 4: metastatic egfr nsclc progressing on osimertinib
-
2:21
treatment of egfr nsclc after progression
-
2:02
case 4: upfront osimertinib in metastatic egfr nsclc
-
5:52
treatment of egfr nsclc after osimertinib
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
0:50
treating patients with egfr-mutant lung cancer with targeted therapies
-
5:18
frontline therapy for egfr plus nsclc: osimertinib’s impact
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
2:59
treatment after progression on osimertinib for egfr nsclc
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
1:02
osimertinib for treatment of egfr lung cancer
-
1:15
osimertinib improves survival in egfr nsclc, poses new challenges for resistance
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
4:39
defining osimertinib’s value in treating egfr nsclc